Clinical Trials · NCT04249232
Abaloparatide and Pelvic Fracture Healing
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- Hospital for Special Surgery, New York
- Enrollment
- 48
- Start date
- Sep 2020
- Locations
- 3 sites, United States
- Primary endpoint
- Efficacy for fracture healing- Measured by participant cortical bridging scores